Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Common Equity (2016 - 2025)

Historic Common Equity for Metlife (MET) over the last 17 years, with Q3 2025 value amounting to $29.2 billion.

  • Metlife's Common Equity fell 633.1% to $29.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 billion, marking a year-over-year decrease of 633.1%. This contributed to the annual value of $27.7 billion for FY2024, which is 842.89% down from last year.
  • Metlife's Common Equity amounted to $29.2 billion in Q3 2025, which was down 633.1% from $27.9 billion recorded in Q2 2025.
  • Metlife's Common Equity's 5-year high stood at $69.4 billion during Q2 2021, with a 5-year trough of $25.3 billion in Q3 2022.
  • Over the past 5 years, Metlife's median Common Equity value was $30.3 billion (recorded in 2023), while the average stood at $38.0 billion.
  • As far as peak fluctuations go, Metlife's Common Equity tumbled by 6346.62% in 2022, and later skyrocketed by 2034.76% in 2024.
  • Metlife's Common Equity (Quarter) stood at $50.0 billion in 2021, then tumbled by 39.77% to $30.1 billion in 2022, then grew by 0.42% to $30.3 billion in 2023, then fell by 8.43% to $27.7 billion in 2024, then rose by 5.37% to $29.2 billion in 2025.
  • Its Common Equity was $29.2 billion in Q3 2025, compared to $27.9 billion in Q2 2025 and $27.8 billion in Q1 2025.